Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

While Washington Stews, You Can Cash In on the Biggest "Tax-Inversion" Deal in History

Back in June 2012, we recommended that you pick up shares of Big Pharma player Abbott Laboratories Inc. (NYSE: ABT). The reason: Abbott was planning to split in two at the end of the year, meaning folks who took our advice would end up with stakes in two companies for the price of one.

There was more than bargain-basement thinking at work here.

You see, these corporate breakups – known as spin-offs – have a habit of turning into market-beating profit plays. And the newly minted spin-off firms often end up as takeover fodder – also at big profits.

Abbott followed part of that blueprint.

  • Forget the Doom-and-Gloom, Now Is a Time to Be Bullish A little girl named Carol Anne became famous for saying "They're h-eee-rrr-e" in the 1982 movie "Poltergeist."
    She was talking about the "TV people."
    Well, we have our equivalent digital denizens, and they're also returning in force lately. Except ours are largely from the investment shadows, awaiting the next opportunity to brandish heavy fear tactics to convince you the energy market is about to collapse... again. (These guys have correctly predicted eight of the last three recessions.)
    At issue this time is the latest financial obstacle the market must overcome: the sequestration scheduled to hit a week from today. The draconian cuts will occur automatically, although it will also take at least a month for them to have any impact. Of course, the markets are not going to wait that long. For the past two days, the first wave of nail biting started.
    But I urge you to ignore those talking heads - and as Congress gets back to "business."
    Here's why. Read More...